The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence

Detalles Bibliográficos
Autores principales: Sang, Ling, Cheng, Bo, Yu, Yuheng, Xi, Yin, Wang, Yun, Fan, Bingdong, Li, Jijie, Dai, Jingtao, Gan, Guifen, Tong, Shijun, Sun, Bin, Qi, Xiaojing, Liang, Wenhua, He, Jianxing, Zhong, Nanshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183246/
https://www.ncbi.nlm.nih.gov/pubmed/35691517
http://dx.doi.org/10.1016/j.jinf.2022.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183246/
https://www.ncbi.nlm.nih.gov/pubmed/35691517
http://dx.doi.org/10.1016/j.jinf.2022.06.004

Ejemplares similares